G-III Apparel (GIII) Queued Up for Q3 Earnings: What to Expect

Published on November 26, 2021

G-III Apparel's (GIII) third-quarter fiscal 2022 results are likely to reflect gains from its brand strength and digital business.

Continue reading on website
Other news

4 Reasons Why You Should Add Sarepta (SRPT) to Your Portfolio

November 26, 2021
Sarepta's (SRPT) stock creates a significant opportunity for investors on the back of solid demand for its commercialized drugs and steady progress with its key pipeline candidates.

Ligand's (LGND) Drug-Developing Technologies Holds Potential

November 26, 2021
Ligand's (LGND) Captisol technology is a key driver for its topline. The company plans to spin off another potential technology platform, OmniAb, into a separate company.